Charles Schwab Investment Management Inc Invitae Corp Transaction History

Charles Schwab Investment Management Inc

$429 Billion
Q1 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	BUY	$0.42 - $0.72 $11,984 - $20,545	28,535 Added 1.36%	2,131,788 $1.34 Million
Q3 2023 Nov 08, 2023	BUY	$0.6 - $1.53 $125,829 - $320,863	209,715 Added 11.08%	2,103,253 $1.26 Million
Q2 2023 Aug 09, 2023	BUY	$1.05 - $1.63 $397,772 - $617,494	378,831 Added 25.01%	1,893,538 $2.14 Million
Q1 2023 May 11, 2023	SELL	$1.2 - $2.73 $284,878 - $648,099	-237,399 Reduced 13.55%	1,514,707 $2.04 Million
Q4 2022 Feb 13, 2023	BUY	$1.71 - $3.61 $211,995 - $447,546	123,974 Added 7.61%	1,752,106 $3.26 Million

Q3 2022 Nov 14, 2022	BUY	$1.9 - $8.63 $22,862 - $103,844	12,033 Added 0.74%	1,628,132 $4.01 Million
Q2 2022 Aug 15, 2022	BUY	$2.13 - $9.01 $79,757 - $337,379	37,445 Added 2.37%	1,616,099 $3.94 Million
Q1 2022 May 13, 2022	BUY	$6.28 - $15.59 $254,277 - $631,239	40,490 Added 2.63%	1,578,654 $12.6 Million
Q4 2021 Feb 11, 2022	BUY	$14.7 - $28.67 $1.08 Million - $2.11 Million	73,764 Added 5.04%	1,538,164 $23.5 Million
Q3 2021 Nov 16, 2021	BUY	$24.31 - $33.6 $2.5 Million - $3.46 Million	102,918 Added 7.56%	1,464,400 $41.6 Million
Q2 2021 Aug 16, 2021	BUY	$26.09 - $40.4 $5.96 Million - $9.22 Million	228,283 Added 20.15%	1,361,482 $45.9 Million
Q1 2021 May 17, 2021	BUY	$33.06 - $56.93 $5.51 Million - $9.48 Million	166,550 Added 17.23%	1,133,199 $43.3 Million
Q4 2020 Feb 16, 2021	BUY	$39.09 - $57.4 $5.43 Million - $7.97 Million	138,869 Added 16.78%	966,649 $40.4 Million
Q3 2020 Nov 13, 2020	BUY	$28.43 - $44.67 $1.73 Million - $2.71 Million	60,746 Added 7.92%	827,780 $35.9 Million
Q2 2020 Aug 14, 2020	BUY	$11.71 - $30.29 $2.53 Million - $6.55 Million	216,377 Added 39.29%	767,034 $23.2 Million
Q1 2020 May 15, 2020	BUY	$7.64 - $27.5 $73,168 - $263,367	9,577 Added 1.77%	550,657 $7.53 Million
Q4 2019 Feb 07, 2020	BUY	$15.02 - $20.57 $272,042 - $372,563	18,112 Added 3.46%	541,080 $8.73 Million
Q3 2019 Nov 08, 2019	BUY	$18.85 - $27.5 $127,350 - $185,790	6,756 Added 1.31%	522,968 $10.1 Million
Q2 2019 Aug 09, 2019	BUY	$17.37 - $26.27 $1.4 Million - $2.12 Million	80,546 Added 18.49%	516,212 $12.1 Million
Q1 2019 May 14, 2019	BUY	$10.65 - $25.75 $786,832 - $1.9 Million	73,881 Added 20.42%	435,666 $10.2 Million
Q4 2018 Feb 14, 2019	BUY	$9.26 - $16.38 $169,069 - $299,066	18,258 Added 5.31%	361,785 $4 Million
Q3 2018 Nov 13, 2018	BUY	$7.54 - $18.31 $156,967 - $381,177	20,818 Added 6.45%	343,527 $5.75 Million
Q2 2018 Aug 08, 2018	BUY	$4.87 - $8.42 $773,282 - $1.34 Million	158,785 Added 96.87%	322,709 $2.37 Million
Q1 2018 May 07, 2018	SELL	$4.69 - $10.05 $375,551 - $804,753	-80,075 Reduced 32.82%	163,924 $769,000
Q4 2017 Jan 17, 2018	BUY	$7.86 - $9.99 $647,357 - $822,786	82,361 Added 50.95%	243,999 $2.22 Million
Q3 2017 Nov 13, 2017	BUY	$8.89 - $10.4 $1.44 Million - $1.68 Million	161,638	161,638 $1.52 Million

Others Institutions Holding NVTA

# of Institutions

Shares Held

7.66M

Call Options Held

Put Options Held

View Full List

About Invitae Corp

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

More about NVTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account